{"url_path":"/sec/tak/10-k/2026/item-16e","section_key":"item-16e","section_title":"Item 16E Purchases of Equity Securities by the Issuer and Affiliated Purchasers","topic":"sec","document":{"doc_type":"20-F","doc_date":"2026-06-17","source_url":"https://www.sec.gov/Archives/edgar/data/1395064/0001395064-26-000177-index.html","accession_number":"0001395064-26-000177","cik":"0001395064","ticker":"TAK","issuer_name":"TAKEDA PHARMACEUTICAL CO LTD","edgar_url":"https://www.sec.gov/Archives/edgar/data/1395064/0001395064-26-000177-index.html","primary_entity_key":"0001395064","primary_entity_name":"TAKEDA PHARMACEUTICAL CO LTD"},"word_count":493,"has_tables":true,"body_markdown":"Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers\n\nThe following table sets forth purchases of our common stock by us and our affiliated purchasers during the fiscal year ended March 31, 2026:\n\nTotal number of\n\nshares purchased*1\nAverage price paid per share (yen)\nTotal number of\n\nshares purchased\n\nas part of publicly\n\nannounced plans\n\nor programs*2\n\nMaximum\n\napproximate value\n\n of shares that may yet be purchased under\n\nthe plans\n\nor programs (billions of yen)\n\nApril 1 to April 30, 2025\n11,823,577 ¥4,227.00 11,823,500 ¥— \n\nMay 1 to May 31, 2025\n401,207 4,052.54 401,100 — \n\nJune 1 to June 30, 2025\n129 4,343.34 — — \n\nJuly 1 to July 31, 2025\n396 4,383.89 — — \n\nAugust 1 to August 31, 2025\n439 4,350.00 — — \n\nSeptember 1 to September 30, 2025\n385 4,497.57 — — \n\nOctober 1 to October 31, 2025\n416 4,295.17 — — \n\nNovember 1 to November 30, 2025\n260 4,305.40 — — \n\nDecember 1 to December 31, 2025\n123 4,473.46 — — \n\nJanuary 1 to January 31, 2026\n199 5,015.35 — — \n\nFebruary 1 to February 28, 2026\n396 5,404.58 — — \n\nMarch 1 to March 31, 2026\n286 5,752.60 — — \n\nTotal12,227,813 ¥4,591.74 12,224,600 ¥— \n\n*1Total number of shares purchased in the above table reflect (a) purchases of shares in relation to stock-based incentive compensation plans, (b) acquisition of own shares in relation to up to the JPY 100.0 billion share buyback approved by our board of directors on January 30, 2025 and (c) purchases of shares constituting less than one “unit” (100 shares).\n\nA total of 3,213 shares were purchased other than through publicly announced plans or programs during the fiscal year ended March 31, 2026, due to our purchase of shares constituting less than one “unit” (100 shares) from holders of shares constituting less than one unit at the current market price of those shares.\n\n*2Total number of shares purchased as part of publicly announced plans or programs in the above table reflect purchases of shares in May 2025 in relation to stock-based incentive compensation plans.\n\nOn May 8, 2025, we announced that our board of directors resolved to continue the stock compensation plan which was introduced as a long-term incentive plan for members of the board of directors in the fiscal year ended March 31, 2017, as well as to continue the stock grant system which was introduced in the fiscal year ended March 31, 2015 as a global long-term incentive plan for Company Group Management in Japan.\n\nOn January 30, 2025, we announced that our board of directors had resolved to approve the repurchase of shares of common stock by us, consisting of a total of up to 28.5 million shares for a total aggregate purchase price of up to JPY 100.0 billion to be purchased through a trust bank between February 17, 2025 and May 31, 2025. Pursuant to this plan, we repurchased an aggregate of 11,823,500 shares during April 2025."}